Healthcare Realty Trust Inc HR.N, HR is expected to show a fall in quarterly revenue when it reports results on February 19 for the period ending December 31 2024
The Nashville Tennessee-based company is expected to report a 7.9% decrease in revenue to $304.34 million from $330.44 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data. (Revenue consensus is on Total Revenue Basis)
LSEG's mean analyst estimate for Healthcare Realty Trust Inc is for a loss of 8 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Healthcare Realty Trust Inc is $18.00, above its last closing price of $16.49.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.38 | 0.38 | 0.39 | Beat | 1.5 |
Jun. 30 2024 | 0.38 | 0.38 | 0.38 | Met | -0.9 |
Mar. 31 2024 | 0.38 | 0.38 | 0.39 | Beat | 1.9 |
Dec. 31 2023 | 0.39 | 0.40 | 0.39 | Missed | -1.6 |
Sep. 30 2023 | 0.39 | 0.39 | 0.39 | Met | -0.2 |
Jun. 30 2023 | 0.40 | 0.40 | 0.39 | Missed | -2.3 |
Mar. 31 2023 | 0.41 | 0.41 | 0.40 | Missed | -2.7 |
Dec. 31 2022 | 0.40 | 0.40 | 0.42 | Beat | 5.1 |
This summary was machine generated February 17 at 13:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。